{"id":15774,"date":"2024-01-22T08:31:30","date_gmt":"2024-01-22T07:31:30","guid":{"rendered":"https:\/\/www.lexxion.eu\/journals\/eplr\/"},"modified":"2026-02-24T16:43:28","modified_gmt":"2026-02-24T15:43:28","slug":"ehpl","status":"publish","type":"journals","link":"https:\/\/www.lexxion.eu\/en\/journals\/ehpl\/","title":{"rendered":"EHPL &#8211; European Health &#038; Pharmaceutical Law Review"},"content":{"rendered":"<p>The <em>European Health &amp; Pharmaceutical Law Review <\/em>(EHPL)\u00a0identifies and analyses important legal and regulatory developments on the national, EU and international level. It is primarily concerned with pharmaceutical law, medicines law and issues related to the work of the European Medicines Agency (EMA).<\/p>\n","protected":false},"featured_media":60769,"template":"","class_list":["post-15774","journals","type-journals","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lexxion.eu\/en\/wp-json\/wp\/v2\/journals\/15774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lexxion.eu\/en\/wp-json\/wp\/v2\/journals"}],"about":[{"href":"https:\/\/www.lexxion.eu\/en\/wp-json\/wp\/v2\/types\/journals"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lexxion.eu\/en\/wp-json\/wp\/v2\/media\/60769"}],"wp:attachment":[{"href":"https:\/\/www.lexxion.eu\/en\/wp-json\/wp\/v2\/media?parent=15774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}